BioAge Labs (BIOA) Operating Margin (2025 - 2026)
BioAge Labs' (BIOA) quarterly Operating Margin came in at 915.4% in Q1 2026, up 21802.0% year-on-year from N/an in Q1 2025, and up 0.87% quarter-over-quarter from 923.42% in Q4 2025.
BioAge Labs (BIOA) Operating Margin (2025 - 2026) Analysis & Trends
BioAge Labs has disclosed Operating Margin across 2 years of filings, most recently posting 915.4% for Q1 2026.
- Operating Margin for Q1 2026 came in at 915.4%, up 21802.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 985.93% (up 465342.0% YoY), and the FY2025 annual result was 1031.46%, changed N/A from the prior year.
- Operating Margin came in at 915.4% for Q1 2026 at BioAge Labs, up from 923.42% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 915.4% in Q1 2026 to a low of 1133.43% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | BioAge Labs | 671.19 Mn | 288.00 Mn | -10.37 Mn | -915.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -915.40% |
| Dec 31, 2025 | -923.42% |
| Sep 30, 2025 | -1,126.58% |
| Jun 30, 2025 | -1,026.99% |
| Mar 31, 2025 | -1,133.43% |